Infant Formula Shortage Update: Where Things Stand

The 2022 US infant formula crisis set the bar for how bad this can get. Nationwide out-of-stock rates hit 70 percent by late May that year, driven by a major contamination recall combined with import restrictions and a heavily concentrated supply market. Store shelves were genuinely empty in parts of the country, and parents were mixing formula from unreliable sources out of desperation. 2026 is not that. National out-of-stock rates were running around 11 percent as of April 2026, a fraction of the 2022 peak, with standard formulas from major brands widely available again. That's real progress, and it's worth saying plainly instead of stoking unnecessary panic.

But "better" isn't the same as "resolved." Specialty formulas, the hypoallergenic and amino-acid-based ones used for babies with allergies or digestive conditions, still see intermittent regional shortages. And this year brought new safety scares that had nothing to do with supply chains and everything to do with contamination.

What Actually Happened in 2026

Two separate incidents shaped this year's formula news, and it's worth knowing the difference between them. In February 2026, a contamination crisis in Europe led major manufacturers Nestlé, Danone, and Lactalis to recall hundreds of batches, prompting Nestlé to run five factories around the clock to prevent a broader shortage. That was a supply response to a safety issue, and it worked reasonably well; European brands stayed largely available through the following months.

Then in June 2026, a more serious event unfolded in the US. The FDA and CDC, working with California's health department, investigated a multistate outbreak of infant botulism linked to a specific organic powdered formula brand, with three confirmed or suspected cases across three states between April and May. The company recalled its full product line once notified.

In clinical practice, this is often missed because parents assume a "shortage" and a "recall" are the same problem with the same fix. They're not. A shortage means find an alternative. A recall means stop using that specific product immediately and check your pantry, regardless of how much is left in the can.

Where This Leaves India-Based Parents

India hasn't experienced anything resembling the US 2022 crisis or the 2026 European contamination scare. The Indian infant formula market has actually been growing steadily, driven by rising urbanization, more working mothers, and expanding product availability through e-commerce. Domestic and internationally established brands remain broadly accessible here. I

That said, parents using imported European or American brands, ordered directly or through specialty retailers, should stay aware of international recall notices, since those products can still reach Indian households through resellers or travel. It's a smaller risk than the headlines suggest, but not a zero risk.

What To Actually Do If You're Facing a Shortage

If your usual formula is temporarily unavailable, the FDA and most pediatric bodies are consistent on one point: never use homemade formula recipes. They circulate widely online and look convincing, but they consistently lack essential nutrients infants need, and they've caused documented harm. This isn't a case where "it's probably fine" applies.

Instead, talk to your pediatrician about a comparable substitute before switching brands, especially for babies on specialty formulas for allergies or reflux. Many clinics keep sample cans on hand precisely for situations like this. Avoid stretching formula by adding extra water to make it last longer; this dilutes essential nutrition and can be dangerous for infants. And if you're building a buffer, a one to two week supply is sensible. Hoarding beyond that just recreates the shortage for someone else's baby.